Need Regulatory Help? Try Our Platform
Post your regulatory questions or request quotations from verified pharmaceutical consultants worldwide. Get matched with experts who specialize in your market.
January 4, 2026
Approximately 5 minutes
Custom-Made Medical Devices in France under EU MDR
Custom-Made Medical Devices in France under EU MDR
Definition of Custom-Made Devices
According to Article 2(3) of Regulation (EU) 2017/745 (MDR), a custom-made device is any device specifically made in accordance with a written prescription of any person authorised by national law by virtue of that person’s professional qualifications which gives, under the person’s responsibility, specific design characteristics, and is intended for the sole use of a particular patient exclusively to meet their individual conditions and needs. Mass-produced devices adapted to meet the specific needs of any particular patient are not considered custom-made. Dispositifs médicaux sur mesure - ANSM
Scope and Exclusions
- Custom-made devices cover a wide range of products, such as dental prostheses, orthopaedic appliances, ocular prostheses, and certain hearing aids made to individual specifications.
- Devices produced in series and then adapted (e.g., standard orthoses adjusted on-site) are not custom-made and must follow standard conformity assessment.
- The MDR applies fully to custom-made devices placed on the market in France, with specific derogations from certain conformity assessment procedures.
Obligations of the Manufacturer
Manufacturers of custom-made devices must:
- Ensure the device meets the general safety and performance requirements set out in Annex I of the MDR.
- Draw up a written declaration in accordance with Annex IV of the MDR.
- Maintain technical documentation as specified in Annex II and Annex III (adapted for custom-made nature).
- Implement a quality management system (QMS) proportionate to the risk class and type of devices.
- Register in EUDAMED and assign a Unique Device Identifier (UDI) where applicable (for certain classes).
- Undertake post-market surveillance and vigilance obligations.
Statement and Documentation Requirements
The manufacturer must draw up a statement containing:
- Name and address of the manufacturer.
- Data allowing identification of the device.
- Statement that the device is intended for the sole use of a particular patient.
- Name of the prescribing healthcare professional.
- Specific characteristics of the device.
- Declaration of conformity with MDR general safety and performance requirements.
This statement must be kept available for competent authorities (e.g., ANSM) for at least 5 years (or 15 years for implantable devices).
Registration and Traceability
- Manufacturers of custom-made devices must register in the EUDAMED actor module and obtain a Single Registration Number (SRN).
- For devices in higher risk classes, additional requirements may apply.
- The prescription and statement must enable traceability to the specific patient.
Conformity Assessment Derogations
Custom-made devices are exempt from the full conformity assessment procedures involving notified bodies (Annexes IX, X, XI), provided the manufacturer complies with the specific obligations above. However, they remain subject to market surveillance by competent authorities.
Practical Considerations in France
- ANSM may request documentation or conduct inspections of custom-made device manufacturers.
- Healthcare professionals prescribing custom-made devices should ensure the prescription contains sufficient detail for safe manufacture.
- Manufacturers are encouraged to consult ANSM for borderline cases or complex custom devices.
- The framework balances flexibility for individual patient needs with appropriate safety and performance safeguards.
This regime ensures that patients in France can access truly individualized medical solutions while maintaining high regulatory standards. Dispositifs médicaux sur mesure - ANSM
Ask Anything
We'll follow up with you personally.
Related Articles
Approximately 5 minutes
Qualification and Classification of Medical Devices and IVDs in France (ANSM Reference)
The ANSM guidance details the qualification (when software or a product is considered a medical device or IVD) and classification rules in France, aligned with EU Regulation 2017/745 (MDR) and 2017/746 (IVDR), including decision trees, borderlines with other product categories, and specific considerations for software, AI, and combination products to support manufacturers in correct regulatory pathway determination.
Approximately 5 minutes
Transitional Provisions for Medical Devices and IVDs in France under EU MDR/IVDR
The ANSM outlines transitional arrangements allowing continued marketing of certain medical devices and IVDs certified under the previous Directives (MDD/AIMDD/IVDD) in France during the extended MDR/IVDR transition periods, subject to specific conditions, validity extensions, and progressive compliance requirements to ensure patient safety during the shift to full MDR/IVDR application.
Approximately 5 minutes
EUDAMED: Key Information for Medical Devices and IVDs in France (ANSM Overview)
The ANSM provides an overview of EUDAMED, the European database for medical devices and IVDs under Regulations (EU) 2017/745 and 2017/746, explaining mandatory registrations, actor roles, device identification (UDI), vigilance reporting, clinical investigations, and transitional provisions for legacy devices in France to support manufacturers and economic operators in compliance.
Approximately 5 minutes
Does Your Health Software or Mobile Application Qualify as a Medical Device or IVD in France?
The ANSM guidance helps determine if a health software or mobile app qualifies as a medical device (DM) or in vitro diagnostic medical device (DMDIV) under EU Regulations 2017/745 (MDR) and 2017/746 (IVDR), providing decision trees, examples, and key criteria based on intended purpose to assist developers and manufacturers in France with correct regulatory classification.
Approximately 5 minutes
Traceability Requirements for Medical Devices in France under EU MDR/IVDR
The ANSM outlines the traceability obligations for medical devices and IVDs in France under Regulations (EU) 2017/745 (MDR) and 2017/746 (IVDR), emphasizing Unique Device Identification (UDI), registration in EUDAMED, supply chain documentation, and vigilance reporting to ensure full product traceability from manufacturer to patient for safety and post-market surveillance.